Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Cyclacel Pharmaceuticals (CYCCP) Competitors

Cyclacel Pharmaceuticals logo

CYCCP vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROW

Should you be buying Cyclacel Pharmaceuticals stock or one of its competitors? The main competitors of Cyclacel Pharmaceuticals include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.

Cyclacel Pharmaceuticals vs.

180 Life Sciences (NASDAQ:ATNFW) and Cyclacel Pharmaceuticals (NASDAQ:CYCCP) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, community ranking, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

Cyclacel Pharmaceuticals received 97 more outperform votes than 180 Life Sciences when rated by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Cyclacel PharmaceuticalsOutperform Votes
97
67.36%
Underperform Votes
47
32.64%

In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.38 beat Cyclacel Pharmaceuticals' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
180 Life Sciences
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cyclacel Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Cyclacel Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Cyclacel PharmaceuticalsN/AN/AN/AN/AN/A

Summary

180 Life Sciences and Cyclacel Pharmaceuticals tied by winning 1 of the 2 factors compared between the two stocks.

Get Cyclacel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYCCP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYCCP vs. The Competition

MetricCyclacel PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$117.40M$5.83B$8.91B
Dividend Yield0.12%3.69%4.75%3.85%
P/E RatioN/A3.2126.7719.24
Price / SalesN/A4,796.44421.6566.67
Price / CashN/A13.0138.0134.83
Price / BookN/A48.067.674.58
Net IncomeN/A-$87.82M$3.19B$245.77M

Cyclacel Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYCCP
Cyclacel Pharmaceuticals
N/A$8.59
+30.2%
N/AN/A$0.00N/A0.0012
ATNFW
180 Life Sciences
N/A$0.01
+6.5%
N/A+9.9%$0.00N/A0.007Gap Down
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
flat
N/A-67.7%$0.00$502,409.000.002Gap Down
DRTSW
Alpha Tau Medical
N/A$0.35
+16.7%
N/A+0.0%$0.00N/A0.0080News Coverage
Gap Down
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
APLMW
Apollomics
N/A$0.01
+9.1%
N/A-55.5%$0.00N/A0.0059Positive News
Gap Up
BCTXW
BriaCell Therapeutics
N/A$0.12
flat
N/A-92.4%$0.00N/A0.008Gap Down
CDIOW
Cardio Diagnostics
N/A$0.07
-4.7%
N/A-56.6%$0.00$35,688.000.007Gap Up
CTCXW
Carmell
N/A$0.04
+59.4%
N/AN/A$0.00$32,839.000.0014Gap Up
CELUW
Celularity
N/A$0.06
+0.2%
N/AN/A$0.00$48.20M0.00220Gap Up
CEROW
CERo Therapeutics
N/A$0.02
+15.4%
N/AN/A$0.00N/A0.008Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:CYCCP) was last updated on 2/24/2025 by MarketBeat.com Staff
From Our Partners